group received titrated oxygen via nasal prongs, with the aim of maintaining arterial oxygen saturation, measured via a pulse oximeter (SpO 2 ) between 88% and 92%. Nebulised therapy was delivered by compressed air. The control group received high flow oxygen (8 to 10 L/min) via a non-rebreather face mask. Nebulised therapy was delivered by compressed oxygen at 6 to 8 L/min. Outcome measures: The primary outcome was pre-and in-hospital mortality. Secondary outcomes were length of hospital stay and blood gas measurements. Results: The primary outcome was captured for all enrolled patients. According to the intention to treat (ITT) analysis, mortality in the intervention and control groups was 4% (n = 7) and 9% (n = 21), respectively. The relative risk was 0.42 (95% CI 0.20 to 0.89). Similar results were demonstrated when only those patients who had a physician-confirmed diagnosis of COPD were included in the analyses (mortality of 2%, n = 2, vs 9%, n = 11, and relative risk of 0.22, 95% CI 0.05 to 0.9]). The ITT analysis did not demonstrate betweengroup differences in the secondary outcomes. Conclusion: In patients with a suspected acute exacerbation of COPD, using titrated oxygen to maintain SpO 2 between 88% and 92% reduced the risk of mortality by 58%. Physiotherapists working in acute care should strive to ensure that these patients are not treated with high-flow oxygen.
Commentary
There is an increased risk of hypercarbia (Plant et al 2000) associated with the use of high levels of oxygen therapy in patients with COPD. High levels of oxygen are reported to cause increased ventilation perfusion mismatch (Sassoon et al 1987) . National (McKenzie et al 2010) and international (O'Driscoll et al 2008) guidelines for the management of COPD recommend the controlled delivery of oxygen following an acute exacerbation of COPD with a target arterial oxygen saturation ranging between 88% and 92% (O'Driscoll et al 2008) .
The trial by Austin et al (2010) provides the first Level 1 evidence that the pre-hospital short-term administration (45 minutes) of a high fraction of inspired oxygen during an acute exacerbation of COPD is associated with worse outcomes that include hypercarbia, respiratory acidosis, and increased mortality. Of note, the average partial pressure of arterial oxygen in the titrated oxygen therapy group was 80 mmHg, in both the intention to treat and the protocol groups, which is considered excessive (O'Driscoll et al 2008) , but this partial pressure still led to significant improvements in patient outcome. Some authors recommend accepting an arterial saturation above 85% (New 2006) as a means of achieving better outcomes, but this requires appropriate investigation.
Titrated oxygen therapy to achieve arterial saturation of between 88% and 92% should be the goal of therapy by physiotherapists who care for patients during acute exacerbations of COPD. The close monitoring of changes in ventilation (carbon dioxide) in response to the delivery of oxygen therapy is also recommended. Further research is required to investigate the impact of oxygen therapy on respiratory function in patients during an acute exacerbation of COPD. 
George Ntoumenopoulos

Commentary
This trial raises two important research questions. First, is TCA more effective than sham acupuncture and waiting list? Second, does provider communication style have an effect on treatment response? The trial provides strong evidence that TCA is not more effective than sham acupuncture. Both interventions were more effective than waiting list though, and, given that the sham procedure was successful, the effect can be considered as a placebo effect. Further, this trial showed that communication style mattered more than the provided treatment with respect to pain perception and satisfaction.
The authors should be acknowledged for their trial design, which enabled them to control for and measure the effects of provider-patient interactions in the response to acupuncture. The use of penetrating needling as sham procedure instead of a sham procedure with retractable needles strengthens the conclusion of no difference in effect between TCA and sham acupuncture.
The strong monitoring with audio taping of the treatment sessions ensured high compliance among the treatment providers. This might have contributed to the significant but small effect of communication style. It is interesting to observe that the main effect of both treatments appeared within the first follow-up at 4 weeks, indicating that the placebo response appeared early. This finding is of clinical importance as a limited number of treatment sessions were enough to achieve a placebo response.
Should we recommend acupuncture to patients with knee OA? The authors do not give us any help here since they do not address this question. On one hand we can say that we can recommend acupuncture since it is better than waiting list, although the positive benefits are probably due to a placebo effect. Placebo is an important positive mechanism to use as a clinician. A warm and positive consultation style can be recommended irrespective of treatment modality. On the other hand, there are ethical considerations by recommending treatments that have shown to contain mainly a placebo effect. Although this trial was about acupuncture, it may make us think about many of our physiotherapy interventions -to consider whether the positive effects we observe and measure are due to the intervention or more to do with the way we deliver the intervention. Question: In people with coronary artery disease, does an expanded cardiac rehabilitation program reduce cardiac deaths, myocardial infarctions, and hospital admissions due to cardiovascular disease? Design: Randomised, controlled trial with intention-to-treat analysis. Setting: A University hospital in Sweden. Participants: People aged less than 75 years who had had a recent myocardial infarction or coronary artery bypass grafts were eligible to participate. Severe co-morbidities were exclusion criteria. Randomisation of 224 participants allocated 111 to undergo expanded cardiac rehabilitation and 113 to a control group. Interventions: Both groups received standard cardiac rehabilitation, including physical training, education, group and individual counselling, and support to cease smoking. All participants received appropriate preventive medications. In addition, the intervention group received 20 group sessions of stress management, 3 sessions of cooking and diet counselling by a dietician, and a 5-day stay at a 'patient hotel' with several activities including physical training and information. Outcome measures: Although other outcomes were reported at the conclusion of 1-year follow-up, the outcomes at the 5-year follow-up were rates of cardiac events: cardiovascular death, acute myocardial infarction, and readmission to a hospital due to other cardiovascular causes. Results: All participants were followed up via national registers of health and mortality. During the 5-year follow-up, 53 (48%) participants in the expanded cardiac rehabilitation group and 68 (60%) participants in the control group had a cardiac event (hazard ratio 0.69, 95% CI 0.48 to 0.99). This difference was mainly due to only 12 (11%) participants having nonfatal myocardial infarctions in the treatment group versus 23 (20%) in the control group (hazard ratio 0.47, 95% CI 0.21 to 0.97). The number of hospitalisations and the number of days of hospitalisation were both significantly fewer in the treatment group than in the control group. Conclusion: Expanded cardiac rehabilitation after acute myocardial infarction or coronary artery bypass surgery reduces the long-term rate of cardiovascular events by reducing myocardial infarctions and days in hospital for cardiovascular reasons.
Margreth Grotle
Commentary
Improving access to effective secondary prevention for people with coronary disease remains a focus of international research. Evidence suggests that secondary prevention programs significantly reduce all-cause mortality, recurrent myocardial infarction, and coronary risk factor profiles, and improve quality of life (Clark et al 2005) . However, the optimal format, including frequency and duration, for secondary prevention programs is unclear so studies with long-term follow-up are needed.
Investigation of long-term outcomes is particularly important in coronary disease because there is an expectation that patients make life-long behavior changes. However, very few studies have reported long-term outcomes of interventions to promote lifestyle modification after cardiac rehabilitation. Three studies found moderate but significant maintenance of improvements in risk factors and medication adherence at four and five years (Neubeck et al 2010 , Lear et al 2006 , Cupples and McKnight 1999 . Another study reported a reduction in cardiovascular events at four years (Murchie et al 2003) .
While the current study is a single-centre study, it includes 224 patients and the authors achieved 100% follow-up for their composite end-point via the available national registries. The intervention itself was multifactorial and an expanded form of traditional cardiac rehabilitation. As the authors point out, it was unfortunate that data about risk factors were not collected at 5-year follow-up. While this information would be of great interest, perhaps the potential for loss to follow-up in such long-term studies remains a major hurdle for researchers.
While this study sheds further light on the topic of longterm outcomes, a key question remains: do the benefits of a time-limited intervention persist over time or do patients require ongoing support via a continuous program? Clearly, this question is of great interest to patients, health care providers, and policy makers in terms of resourcing and optimum program design.
Julie Redfern The George Institute for Global Health;
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